Key Insights

Highlights

Success Rate

100% trial completion (above average)

Research Leaders

6 sponsors active, led by Pfizer

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02318524Completed

Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients

NCT01958710UnknownPrimary

Outcome After Treatment of Pulmonary Aspergilloma

Showing all 2 trials

Research Network

Active Sponsors

  • Pfizer1
  • Merck Sharp & Dohme LLC1
  • Région Nord-Pas de Calais, France1
  • University Hospital, Gasthuisberg1
  • University Hospital, Lille1

Top Investigators

Related Conditions

  • Environmental Exposure1
  • Copd1

Activity Timeline